Articles Archive - Page 311 of 321

TNF Inhibitors & RA

Richard Quinn | March 24, 2014

Anti-tumor necrosis factor agents may have cardioprotective effects in rheumatoid arthritis patients

Let the ICD-10 Testing Begin

Kimberly Retzlaff | March 13, 2014

CMS holds ICD-10 testing in March; plans for summer tests

Approval Expected for Apremilast

Richard Quinn | March 5, 2014

New drug shows promise in treating psoriatic arthritis, ankylosing spondylitis & psoriasis

Human RNAi Therapy Jumps Hurdle

Lara C. Pullen, PhD | February 20, 2014

A new proof-of-concept human study brings RNA interference therapy one step closer to market. (published March 3, 2014)

Microbiome Research Provides Clue to Rheumatoid Arthritis

Lara C. Pullen, PhD | February 20, 2014

A new study suggests that intestinal expansion of Prevotella copri may be associated with the pathogenesis of RA

Glaxo’s Move on Physician Compensation Could Signal Shift in Pharmaceutical Promotions

Richard Quinn | February 14, 2014

GlaxoSmithKline has decided to stop paying physicians to promote its products and to cease tying sales-representative compensation to the number of prescriptions physicians write. (posted Feb. 14)

Do Women Receive Worse Gout Treatment Than Men?

Richard Quinn | February 5, 2014

Women with gout are more likely to have contraindications to nonsteroidal antiinflammatory drugs and are less likely to receive urate-lowering drugs than men with the disease. (posted Feb. 5)

Interleukin 1-alpha Is Critical for Establishment of Inflammatory Lung Disease

Lara C. Pullen, PhD | January 21, 2014

New research clarifies the role of fibroblasts in chronic lung disease. (posted Jan. 21)

Does Anti-Tumor Necrosis Factor-Alpha Increase Cardiovascular Burden?

Lara C. Pullen, PhD | January 14, 2014

Long-term use of TNFα inhibitors in patients with rheumatoid arthritis and ankylosing spondylitis is associated with both gains in fat mass and a shift in fat mass to the visceral region. (posted Jan. 14)

Joint Smart Coalition Takes on Psoriasis in New York City

Richard Quinn | December 13, 2013

The Arthritis Foundation and the National Psoriasis Foundation launched the Joint Smart Coalition to focus on patient education, resources, and outreach. At a coalition-sponsored community-outreach event at Queens College in Flushing, N.Y., attendees were provided information on setting goals, stretching techniques, easy exercises, treatment options, and tips for a healthy lifestyle. (posted Dec. 13)